This is a $93,530 cost-reimbursement delivery order awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc., a non-profit healthcare organization. The order is part of the Vaccine Safety Datalink (VSD) master contract, an indefinite-delivery, indefinite-quantity (IDIQ) vehicle with a potential value of $149 million. Under this task order, Marshfield Clinic will provide linked healthcare data, scientific expertise, and technical support to enable the CDC to...
The Centers for Disease Control and Prevention awarded a $586,786 delivery order against the Vaccine Safety Datalink Project master indefinite-delivery/indefinite-quantity contract to Marshfield Clinic Health System, Inc. This funding will support the Vaccine Safety Datalink Project, which collects data to research vaccine safety and conduct studies for the CDC. The single award was made to Marshfield Clinic as the prime contractor for work taking place in Marshfield, Wisconsin through...
This federal contract award, with ID HHSD200201457941C, was issued by the Centers for Disease Control and Prevention (CDC) to the prime contractor Marshfield Clinic, Inc., a non-profit healthcare organization. The $435,047.82 definitive cost-no-fee contract is for vaccine safety data link services, linking databases from managed care organizations and health plans to enable the CDC to study vaccine safety issues and conduct rapid analyses. This contract is part of the Vaccine Safety Datalink...
The Centers for Disease Control and Prevention awarded a $1.6 million delivery order to Marshfield Clinic under the Vaccine Safety Datalink Project master indefinite-delivery/indefinite-quantity contract. Marshfield Clinic will provide vaccine safety data analysis services through September 2024 in support of the CDC's efforts to monitor the safety of vaccines and conduct research related to vaccine safety issues. As the prime contractor, Marshfield Clinic will leverage its expertise and...
This is a delivery order awarded by the Centers for Disease Control and Prevention (CDC), which is part of the Department of Health and Human Services (HHS), to Marshfield Clinic, Inc., a non-profit healthcare organization. The $318,810.00 contract is for services related to the Vaccine Safety Datalink (VSD) Project, an ongoing initiative that monitors vaccine safety. The VSD Project is managed through an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle, and this delivery order is...
This is a firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc., a non-profit healthcare organization. The contract, titled "MMR3 LONG TERM FOLLOW UP STUDY", has a ceiling value of $280,051 and an ultimate completion date of June 4, 2022. The contract does not have a set-aside designation. Marshfield Clinic, Inc. is the prime contractor, and there are no subcontractors mentioned. This contract is part of the Vaccine...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc., a non-profit healthcare organization, for a project titled "USING ELECTRONIC HEALTH RECORDS TO IDENTIFY AND DESCRIBE". The contract has a ceiling value of $1,029,344.00 and a period of performance ending on September 27, 2027. It is a firm fixed price contract and was not set aside for any particular business type. Marshfield Clinic, Inc. is a subsidiary of...
The Centers for Disease Control and Prevention (CDC) awarded a $658,016 definitive contract to Marshfield Clinic, Inc. for "OPTIMAL STRATEGIES TO ESTIMATE THE RELATIVE EFFECTIVENESS OF INFLUENZA VACCINES". This contract, which has a term ending on March 17, 2025, is not set aside. Marshfield Clinic, Inc., a non-profit healthcare organization, will be providing services related to evaluating the effectiveness of influenza vaccines. This contract is part of a larger Vaccine Safety...
This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Marshfield Clinic, Inc. for a follow-up study to assess immunogenicity associated with a third dose of the measles-mumps-rubella (MMR) vaccine. The contract has a total potential value of $99,565.00 and a completion date of July 31, 2019. Marshfield Clinic is the only source with access to the cohort of 665 subjects who are clients of the clinic, and the contract is sole-sourced under the...
This is a federal contract awarded to Marshfield Clinic, Inc., a non-profit healthcare organization, by an unnamed U.S. government agency. The contract, which is a Definitive Contract with a Cost No Fee pricing type, has a potential value of $61,350,749.00 and was awarded on June 25, 1999 with a completion date of January 31, 2007. The contract does not have a set-aside designation. Marshfield Clinic, which has a history of partnering with government agencies like the Centers for Disease Control...